Catalyst Wire Dossier Catalyst Wire Dossier

Emapalumab

emapalumab · Novo Nordisk
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Emapalumab, covering 2022-01-26 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis

See pricing